William Blair & Company
PRVA icon

William Blair & Company’s Privia Health PRVA Stock Holding History

William Blair & Company’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Sell
18,477
-245
-1% -$5.67K ﹤0.01% 1252
2026
Q1 		$385K Sell
18,722
-1,277
-6% -$28.8K ﹤0.01% 1240
2025
Q4 		$474K Buy
19,999
+400
+2% +$9.74K ﹤0.01% 1163
2025
Q3 		$488K Sell
19,599
-40
-0.2% -$861 ﹤0.01% 1125
2025
Q2 		$452K Hold
19,639
– – ﹤0.01% 1117
2025
Q1 		$441K Hold
19,639
– – ﹤0.01% 1120
2024
Q4 		$384K Buy
19,639
+25
+0.1% +$495 ﹤0.01% 1184
2024
Q3 		$357K Sell
19,614
-29,100
-60% -$555K ﹤0.01% 1228
2024
Q2 		$847K Sell
48,714
-2,850
-6% -$50.5K ﹤0.01% 934
2024
Q1 		$1.01M Buy
51,564
+28,689
+125% +$606K ﹤0.01% 862
2023
Q4 		$527K Sell
22,875
-723,320
-97% -$16.2M ﹤0.01% 1057
2023
Q3 		$17.2M Buy
746,195
+57,881
+8% +$1.47M 0.07% 217
2023
Q2 		$18M Sell
688,314
-107,006
-13% -$2.83M 0.07% 217
2023
Q1 		$22M Buy
795,320
+83,029
+12% +$2.19M 0.09% 192
2022
Q4 		$16.2M Buy
712,291
+40,325
+6% +$1.12M 0.07% 220
2022
Q3 		$22.9M Buy
671,966
+56,824
+9% +$2.1M 0.11% 173
2022
Q2 		$17.9M Buy
615,142
+597,730
+3,433% +$15.2M 0.08% 207
2022
Q1 		$465K Buy
17,412
+1,463
+9% +$34.5K ﹤0.01% 1181
2021
Q4 		$413K Buy
+15,949
New +$398K ﹤0.01% 1292

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

William Blair & Company's PRVA Position: Q2 2026 in Review

William Blair & Company reduced its Privia Health (PRVA) stake by 1.3% in Q2 2026, selling an estimated $5.67K and leaving 18,477 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

William Blair & Company first reported a position in PRVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $22.9M in Q3 2022. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • William Blair & Company held 18,477 shares of Privia Health worth $475K as of Q2 2026.
  • William Blair & Company sold 245 Privia Health shares in Q2 2026, an estimated $5.67K.
  • Privia Health made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1252 holding.
  • William Blair & Company first reported a position in Privia Health in Q4 2021 and has held it in 19 quarters since.
  • William Blair & Company's Privia Health position peaked at $22.9M in Q3 2022.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.